What did @calxshreds actually say?
The creator walks through a specific injection technique: ditch the standard 23-25 gauge intramuscular needle, draw your testosterone oil with a larger 21-gauge needle, then backfill a smaller insulin-style needle (27-29 gauge, 0.5 inch) by pulling the plunger out and loading oil directly. The pitch is blunt: this will "reduce scar tissue" and "reduce post injection pain" by an "absolute mile." He also recommends pre-filling two weeks worth of syringes and leaving a tiny air bubble so "solvents don't sit on the rubber."
The core claim is that smaller-bore needles cause less tissue trauma and post-injection pain than the larger needles typically used for intramuscular testosterone. That is a testable, specific claim. Let's look at what the evidence actually says.
Does the science back this up?
Mostly, yes, with some important caveats. The evidence for smaller needle gauges reducing injection-site pain is real, and subcutaneous testosterone administration has legitimate clinical support. A 2012 randomized trial by Spratt et al. in the Journal of Clinical Endocrinology and Metabolism found that subcutaneous testosterone cypionate produced comparable serum testosterone levels to intramuscular delivery with a better tolerability profile. A 2017 study by Olsson et al. in Andrology confirmed subcutaneous administration was well-tolerated with minimal local reactions when using small-gauge needles.
On needle gauge specifically, the relationship between needle bore and injection pain is supported by basic tissue mechanics. Larger-gauge needles displace more tissue. A 2016 review by Hirsch et al. in Diabetes Care, though focused on insulin delivery, confirmed that shorter, finer needles reduced pain scores significantly. The principle transfers. The backfilling technique itself is a pragmatic workaround for the viscosity of oil-based testosterone esters, which genuinely resist flow through narrow-bore needles.
What did they get wrong (or right)?
Credit where it is due: the fundamental advice is directionally correct. Smaller needles, shallower injections, less trauma. The clinical literature supports this. But several specific claims overreach or introduce real risk.
First, the "absolute mile" framing on scar tissue reduction. Scar tissue formation from TRT injections is multifactorial. Injection site rotation, injection frequency, testosterone concentration, and the carrier oil all contribute. A 27-gauge needle alone is not a guaranteed fix. Overpromising here sets users up to ignore other important variables.
Second, and more concerning: pre-filling syringes two weeks at a time creates sterility and stability risks that the creator does not address. Testosterone cypionate in oil is relatively stable, but once you pull it into a plastic syringe and expose it to a pulled-out plunger, contamination risk exists. No peer-reviewed guidance endorses multi-week pre-filling of hormone injections at home. The American Urological Association and Endocrine Society guidelines make no recommendation supporting this practice.
Third, the air bubble comment about "solvents not sitting on the rubber" reflects a real concern about benzyl alcohol and benzyl benzoate degrading rubber stoppers over long contact periods, but this is not well-characterized at the timescales he describes and should not be presented as settled science.
What should you actually know?
If you are on a prescribed TRT protocol and experiencing significant injection pain, subcutaneous administration with a 27-29 gauge needle is a legitimate, clinically studied option worth discussing with your prescribing provider. The Spratt 2012 data is solid. The backfilling technique is a reasonable mechanical workaround for oil viscosity, and many compounding pharmacies and clinical protocols acknowledge it.
What you should not do is pre-load two weeks of syringes based on a TikTok video. Sterile technique matters. Single-use preparation minimizes contamination risk. Your pharmacist and prescriber are the right people to ask about needle gauge, injection route, and preparation technique for your specific formulation.
One more thing: the 0.5-inch needle depth is appropriate for subcutaneous fat in many people, but body composition varies. A very lean individual may hit muscle anyway. A person with more subcutaneous tissue may not achieve adequate absorption. Injection depth is not one-size-fits-all, and that nuance is absent from the video entirely.